Tag: asco abstract 2022
Updates On the ASCO 2022 Annual Meeting
Updates On the ASCO 2022 Annual Meeting
0
0
0
18 Jul, 07:30 AM
Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Versus bevacizumab (BEV) + mFOLFOX6
Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Versus bevacizumab (BEV) + mFOLFOX6
0
0
0
8 Jul, 10:01 AM
Junshi’s domestic Toripalimab’s significant results in recurrent or metastatic HNSCC. CRL issued on Nasopharyngeal Carcinoma could prove to be a setback?
Junshi’s domestic Toripalimab’s significant results in recurrent or metastatic HNSCC. CRL issued on Nasopharyngeal Carcinoma could prove to be a setback?
0
0
0
29 Jun, 10:32 AM
Is Paxalisib Better Than Temozolomide In The First-Line Setting?
Paxalisib showed positive and promising results in the phase II trial. (Abstract #2407)
0
0
0
24 Jun, 09:29 AM
With The Emergence of Next-Generation SERDs, Sanofi Might Hit The Mark
With The Emergence of Next-Generation SERDs, Sanofi Might Hit The Mark
0
0
0
24 Jun, 07:22 AM
